Active Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The U.S. Department of Health and Human Services is seeking information on antifungal development for drug-resistant fungal infections. This RFI aims to gather insights from potential partners to inform future acquisitions and programs. Responses are encouraged from both small and other than small businesses to enhance BARDA's understanding of the marketplace.
The Center for the Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), is issuing this Request for Information (RFI) to collect feedback from current and prospective antifungal development partners. Information obtained from this RFI will serve as continued planning for potential future acquisitions and programs. The information collected in response to this RFI is intended to strengthen BARDA’s understanding of the current and future marketplace. This notice seeks information from Other than Small Businesses (OTSB) and Small Businesses (SB) regarding their qualifications, experience, and capabilities.
RFI - MEDICAL COUNTERMEASURES FOR THE TREATMENT OF DRUG-RESISTANT FUNGAL INFECTIONS is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.